Pre-earnings options volume in CTI BioPharma is 1.7x normal with calls leading puts 16:1. Implied volatility suggests the market is anticipating a move near 9.1%, or 46c, after results are released. Median move over the past eight quarters is 8.5%.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on CTIC: